SciELO - Scientific Electronic Library Online

 
vol.132 número4Desigualdad en mortalidad infantil entre las comunas de la provincia de SantiagoHepatitis crónica y cirrosis por virus C pre y post trasplante hepático en una niña de 9 años: Report of one case índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista médica de Chile

versión impresa ISSN 0034-9887

Resumen

QUIROGA L, Pilar; ALBALA B, Cecilia  y  KLAASEN P, Gonzalo. Validation of a screening test for age associated cognitive impairment, in Chile . Rev. méd. Chile [online]. 2004, vol.132, n.4, pp.467-478. ISSN 0034-9887.  http://dx.doi.org/10.4067/S0034-98872004000400009.

Background: The real prevalence of dementia in a given population must be determined through prevalence studies, using validated screening tests. Aim: To validate and determine cutoff points for a cognitive impairment screening test composed by the Folstein Mini Mental State Examination (MMSE) and Pfeffer Functional Activities Questionnaire (PFAQ). Material and methods: Validation of the diagnostic test in a sample of 100 subjects over 65 years old (85 from the project «Age associated dementias» and 15 with a confirmed diagnosis of dementia). All were subjected to a complete neuropsychological test by a trained neurologist, that constituted the «gold standard» for the diagnosis of dementia. An independent interviewer applied the MMSE to the subjects and the PFAQ to a next of kin informer. Cutoff points were calculated using ROC curves. The points with the better equilibrium between sensitivity and specificity were selected, considering differences in results between groups with low and high educational level. Results: The cutoff point for MMSE was 21/22, with a sensitivity of 93.6% (95% CI 70.6-99.7%) and a specificity of 46.1% (95% CI 34.7-57.8%). The figure for PFAQ was 5/6, with a sensitivity of 89.2% (95% CI 70.6-99.7%) and a specificity of 70.7% (95% CI 58.9-80.3%). The combination of both instruments gave a sensitivity of 94.4% (95% CI 58.9-80.3%) and a specificity of 83.3% (95% CI 72.3-90.7%). Conclusions: This screening test, using MMSE and PFAQ, has a good sensitivity and specificity for the diagnosis of dementia in Chile. Being simple and of low cost, it can be applied in primary health care (Rev Méd Chile 2004; 132: 467-78)

Palabras clave : Cognition disordes; Cognitive symptoms; Dementia.

        · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons